Jens Pedersen Selected Research

Jens Pedersen Research Topics

Disease

8	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2006
6	Obesity 01/2021 - 12/2011
4	Hyperglycemia 10/2019 - 06/2016
4	Neoplasms (Cancer) 07/2019 - 11/2016
3	Short Bowel Syndrome 05/2022 - 01/2019
3	Insulin Resistance 12/2020 - 01/2017
3	Non-alcoholic Fatty Liver Disease 12/2020 - 11/2016
3	Glucose Intolerance 10/2019 - 04/2016
2	Liver Diseases (Liver Disease) 01/2022 - 07/2019
2	Dyslipidemias (Dyslipidemia) 07/2019 - 01/2019
2	Glucagonoma 07/2019 - 01/2017
2	Hyperplasia 01/2018 - 01/2017
2	Body Weight (Weight, Body) 01/2018 - 12/2011
2	Congenital Heart Defects (Congenital Heart Defect) 07/2011 - 12/2005
1	Intestinal Failure 01/2022
1	Hypertension (High Blood Pressure) 01/2020
1	Fatty Liver 10/2019
1	Hyperinsulinism (Hyperinsulinemia) 10/2019
1	Hyperphagia (Overeating) 10/2019
1	Metabolic Diseases (Metabolic Disease) 07/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Colonic Neoplasms (Colon Cancer) 10/2018
1	Colorectal Neoplasms (Colorectal Cancer) 10/2018
1	Mucositis 01/2018
1	Hypertrophy 01/2018
1	Inflammation (Inflammations) 01/2018
1	Body Weight Changes 01/2018
1	Pain (Aches) 01/2018
1	Necrolytic Migratory Erythema 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2013

Drug/Important Bio-Agent (IBA)

12	Glucagon (Glukagon)FDA Link 05/2022 - 04/2016
8	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 04/2006
8	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 04/2006
4	Amino Acids FDA Link 12/2020 - 01/2017
4	Glucagon Receptors (Glucagon Receptor)IBA 10/2019 - 01/2017
3	Alanine (L-Alanine)FDA Link 12/2020 - 01/2018
3	Insulin (Novolin)FDA Link 10/2019 - 06/2016
3	IncretinsIBA 10/2019 - 04/2006
3	Hormones (Hormone)IBA 04/2016 - 04/2006
3	Peptides (Polypeptides)IBA 12/2012 - 04/2006
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
2	gastric inhibitory polypeptide receptorIBA 04/2016 - 12/2011
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	Cholecystokinin B ReceptorIBA 01/2021
1	Cholecystokinin (Pancreozymin)IBA 01/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2019
1	LipidsIBA 10/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2019
1	IntegrinsIBA 10/2018
1	StilbenesIBA 10/2018
1	tetraiodothyroacetic acid (TA(4))IBA 10/2018
1	ResveratrolIBA 10/2018
1	nano-diamino-tetracIBA 10/2018
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	EnzymesIBA 01/2018
1	teduglutideIBA 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Exenatide (Byetta)FDA Link 01/2018
1	A 7 (A-7)IBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Xylazine (Xylazin)IBA 06/2016
1	Midazolam (Versed)FDA LinkGeneric 06/2016
1	Isoflurane FDA LinkGeneric 06/2016
1	HypnormIBA 06/2016
1	Ketamine FDA LinkGeneric 06/2016
1	Pentobarbital (Nembutal)FDA Link 06/2016
1	Anesthetics (Anesthetic Agents)IBA 06/2016
1	NeurotensinIBA 12/2012
1	Secretin FDA Link 12/2012

Therapy/Procedure

2	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2016 - 10/2015
1	Subcutaneous Injections 05/2022
1	Therapeutics 01/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Anesthesia 06/2016
1	Catheters 07/2011
1	Length of Stay 12/2005